Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

2.5K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
2.5K
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action01:17

Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action

2.3K
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
2.3K
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

3.2K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
3.2K
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

3.0K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
3.0K
Analgesia and Pain Management01:25

Analgesia and Pain Management

962
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
962
Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

4.0K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
4.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Functional Analysis of Ligand-Gated Chloride Channels in a Cnidarian Sheds Light on the Evolution of Inhibitory Signaling.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Screening assay to monitor mono-ADP-ribosylhydrolase activity of viral macrodomains in cells.

Communications biology·2026
Same author

MiMiCPy-FM: A User-Friendly Force Matching Tool for Extending the Time Scale of QM/MM MD MiMiC Simulations.

Journal of chemical information and modeling·2026
Same author

Binding pose depth modulates photoswitchable ligands' efficacy at the 5-HT<sub>2A</sub> receptor.

Communications chemistry·2026
Same author

From Atoms to Neuronal Spikes: A Multiscale Simulation Framework.

Journal of chemical theory and computation·2026
Same author

Multiscale Computational Dissection of CCRL2-Mediated Chemerin Presentation.

Journal of chemical information and modeling·2025
Same journal

Rational Development of Activatable Prodrugs of the GSTP1 Inhibitor NBDHEX: Turn-On NIR Fluorogenic Drug Delivery with Selective Anticancer Activity.

Journal of medicinal chemistry·2026
Same journal

Recent Highlights in the Discovery and Design of Antibody-Drug Conjugates.

Journal of medicinal chemistry·2026
Same journal

One Face, Three Solutions: Structural Convergence in PD-L1 Inhibition across Antibodies, Macrocycles, and Small Molecules.

Journal of medicinal chemistry·2026
Same journal

A Potent and Selective Quinolone-Based PTPN22 Inhibitor with Improved Immunotherapeutic Activity.

Journal of medicinal chemistry·2026
Same journal

Structure-Based Discovery of (<i>E</i>)- and (<i>Z</i>)-4-Oxobut-2-enoate Derivatives as Novel Covalent Pin1 Inhibitors with Antitumor Activity.

Journal of medicinal chemistry·2026
Same journal

Hybrids of Benzenesulfonamide Oxadiazole Derivatives with Dual CA II and COX-2 Inhibitory Activity Demonstrating Antiglaucoma and Anti-inflammatory Action: Synthesis, In Silico Insights, and In Vitro and In Vivo Bioevaluation.

Journal of medicinal chemistry·2026
See all related articles

Related Experiment Video

Updated: Oct 22, 2025

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b
10:20

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b

Published on: November 11, 2016

8.7K

Dynorphin Neuropeptides Decrease Apparent Proton Affinity of ASIC1a by Occluding the Acidic Pocket.

Lilia Leisle1, Michael Margreiter2,3, Audrey Ortega-Ramírez1

  • 1Institute of Physiology, RWTH Aachen University, 52074 Aachen, Germany.

Journal of Medicinal Chemistry
|August 31, 2021
PubMed
Summary
This summary is machine-generated.

Acidosis during stroke kills neurons through acid-sensing ion channel 1a (ASIC1a). Opioid big dynorphin (Big Dyn) modulates ASIC1a activity, with its binding stabilizing the channel and reducing acid sensitivity.

More Related Videos

Preparation and Delivery of Protein Microcrystals in Lipidic Cubic Phase for Serial Femtosecond Crystallography
09:09

Preparation and Delivery of Protein Microcrystals in Lipidic Cubic Phase for Serial Femtosecond Crystallography

Published on: September 20, 2016

11.6K
Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
16:02

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Published on: February 10, 2023

2.9K

Related Experiment Videos

Last Updated: Oct 22, 2025

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b
10:20

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b

Published on: November 11, 2016

8.7K
Preparation and Delivery of Protein Microcrystals in Lipidic Cubic Phase for Serial Femtosecond Crystallography
09:09

Preparation and Delivery of Protein Microcrystals in Lipidic Cubic Phase for Serial Femtosecond Crystallography

Published on: September 20, 2016

11.6K
Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
16:02

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Published on: February 10, 2023

2.9K

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biochemistry

Background:

  • Prolonged acidosis, common in ischemic stroke, causes neuronal death by activating acid-sensing ion channel 1a (ASIC1a).
  • Acidosis also desensitizes ASIC1a, making modulators of its acid sensitivity critical for understanding stroke pathophysiology.
  • The opioid neuropeptide big dynorphin (Big Dyn) enhances ASIC1a activity during acidosis, but the molecular details of this interaction are unknown.

Purpose of the Study:

  • To elucidate the molecular determinants and dynamics of the interaction between big dynorphin (Big Dyn) and acid-sensing ion channel 1a (ASIC1a).
  • To understand how Big Dyn binding affects ASIC1a function and proton sensitivity.

Main Methods:

  • Computational molecular modeling to visualize Big Dyn interaction with ASIC1a.
  • Experimental validation of electrostatic forces driving the interaction.
  • Utilizing noncanonical amino acids as photo-cross-linkers to identify ASIC1a binding residues.
  • Covalent tethering of Big Dyn to ASIC1a to assess functional consequences.

Main Results:

  • A molecular model revealed Big Dyn insertion into ASIC1a's acidic pocket.
  • Electrostatic forces were confirmed as the primary drivers of the Big Dyn-ASIC1a interaction.
  • Sixteen ASIC1a residues were identified as crucial for Big Dyn binding.
  • Covalently linking Big Dyn to ASIC1a significantly reduced channel proton sensitivity.

Conclusions:

  • Big dynorphin (Big Dyn) interacts with acid-sensing ion channel 1a (ASIC1a) via electrostatic forces, with specific residues mediating binding.
  • Big Dyn binding stabilizes ASIC1a in a resting conformation, decreasing its sensitivity to protons.
  • This interaction suggests a novel mechanism by which neuropeptides modulate ion channel activity in neurological conditions like stroke.